Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
European Journal of Endocrinology|August 18, 2009
Cardiovascular risk factors in hypopituitary GH-deficient adultsJohan Verhelst, Roger Abs
Drugs|October 25, 2002
Long-term growth hormone replacement therapy in hypopituitary adultsJohan Verhelst, Roger Abs
Treatments in Endocrinology|May 6, 2005
Hyperprolactinemia: pathophysiology and managementJohan Verhelst, Roger Abs
European Journal of Endocrinology|February 19, 2009
Characterization of resistance to the prolactin-lowering effects of cabergoline in macroprolactinomas: a study in 122 patientsEtienne Delgrange, Tania Daems, Johan Verhelst, et al.
European Journal of Endocrinology|November 7, 2007
Optimalization and cost management of lanreotide-Autogel therapy in acromegalyPascale Abrams, Orsalia Alexopoulou, Roger Abs, et al.
Endocrine Connections|April 18, 2018
The prevalence of the metabolic syndrome and associated cardiovascular complications in adult-onset GHD during GH replacement: a KIMS analysisJohan Verhelst, Anders F Mattsson, Cecilia Camacho-Hübner, et al.
Pituitary|March 20, 2008
Modification of hormonal secretion in clinically silent pituitary adenomasTania Daems, Johan Verhelst, Alex Michotte, et al.
Diabetes Care|November 15, 2011
Incidence of diabetes mellitus and evolution of glucose parameters in growth hormone-deficient subjects during growth hormone replacement therapy: a long-term observational studyAnton Luger, Anders F Mattsson, Maria Koltowska-Häggström, et al.
European Journal of Endocrinology|October 5, 2011
Prevalence and characteristics of the metabolic syndrome in 2479 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysisJohan Verhelst, Anders F Mattsson, Anton Luger, et al.
European Journal of Endocrinology|December 6, 2012
Prevalence of diabetes mellitus in 6050 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysisRoger Abs, Anders F Mattsson, Maria Thunander, et al.
Pageof 4